BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 34353956)

  • 21. The molecular architecture of HIV.
    Briggs JA; Kräusslich HG
    J Mol Biol; 2011 Jul; 410(4):491-500. PubMed ID: 21762795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure and assembly of immature HIV.
    Briggs JA; Riches JD; Glass B; Bartonova V; Zanetti G; Kräusslich HG
    Proc Natl Acad Sci U S A; 2009 Jul; 106(27):11090-5. PubMed ID: 19549863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allosteric Regulation of HIV-1 Capsid Structure for Gag Assembly, Virion Production, and Viral Infectivity by a Disordered Interdomain Linker.
    Koma T; Kotani O; Miyakawa K; Ryo A; Yokoyama M; Doi N; Adachi A; Sato H; Nomaguchi M
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inositol phosphates are assembly co-factors for HIV-1.
    Dick RA; Zadrozny KK; Xu C; Schur FKM; Lyddon TD; Ricana CL; Wagner JM; Perilla JR; Ganser-Pornillos BK; Johnson MC; Pornillos O; Vogt VM
    Nature; 2018 Aug; 560(7719):509-512. PubMed ID: 30069050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-1 assembly, budding, and maturation.
    Sundquist WI; Kräusslich HG
    Cold Spring Harb Perspect Med; 2012 Jul; 2(7):a006924. PubMed ID: 22762019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of HIV-1 Matrix-Envelope Cytoplasmic Tail Interactions.
    Alfadhli A; Staubus AO; Tedbury PR; Novikova M; Freed EO; Barklis E
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31375589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Replication of HIV-1 envelope protein cytoplasmic domain variants in permissive and restrictive cells.
    Staubus AO; Alfadhli A; Barklis RL; Barklis E
    Virology; 2019 Dec; 538():1-10. PubMed ID: 31550607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solution structure of calmodulin bound to the binding domain of the HIV-1 matrix protein.
    Vlach J; Samal AB; Saad JS
    J Biol Chem; 2014 Mar; 289(12):8697-705. PubMed ID: 24500712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cryo-ET of Env on intact HIV virions reveals structural variation and positioning on the Gag lattice.
    Mangala Prasad V; Leaman DP; Lovendahl KN; Croft JT; Benhaim MA; Hodge EA; Zwick MB; Lee KK
    Cell; 2022 Feb; 185(4):641-653.e17. PubMed ID: 35123651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail.
    Wyma DJ; Jiang J; Shi J; Zhou J; Lineberger JE; Miller MD; Aiken C
    J Virol; 2004 Apr; 78(7):3429-35. PubMed ID: 15016865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle.
    Lee SK; Harris J; Swanstrom R
    J Virol; 2009 Sep; 83(17):8536-43. PubMed ID: 19515760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Roles played by acidic lipids in HIV-1 Gag membrane binding.
    Olety B; Ono A
    Virus Res; 2014 Nov; 193():108-15. PubMed ID: 24998886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A highly conserved residue in the C-terminal helix of HIV-1 matrix is required for envelope incorporation into virus particles.
    Brandano L; Stevenson M
    J Virol; 2012 Feb; 86(4):2347-59. PubMed ID: 22156517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dominant Negative MA-CA Fusion Protein Is Incorporated into HIV-1 Cores and Inhibits Nuclear Entry of Viral Preintegration Complexes.
    Anderson-Daniels J; Singh PK; Sowd GA; Li W; Engelman AN; Aiken C
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31413124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein.
    Tang C; Ndassa Y; Summers MF
    Nat Struct Biol; 2002 Jul; 9(7):537-43. PubMed ID: 12032547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organization of immature human immunodeficiency virus type 1.
    Wilk T; Gross I; Gowen BE; Rutten T; de Haas F; Welker R; Kräusslich HG; Boulanger P; Fuller SD
    J Virol; 2001 Jan; 75(2):759-71. PubMed ID: 11134289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An atomic model of HIV-1 capsid-SP1 reveals structures regulating assembly and maturation.
    Schur FK; Obr M; Hagen WJ; Wan W; Jakobi AJ; Kirkpatrick JM; Sachse C; Kräusslich HG; Briggs JA
    Science; 2016 Jul; 353(6298):506-8. PubMed ID: 27417497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.
    Ono A; Orenstein JM; Freed EO
    J Virol; 2000 Mar; 74(6):2855-66. PubMed ID: 10684302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A conformational transition observed in single HIV-1 Gag molecules during in vitro assembly of virus-like particles.
    Munro JB; Nath A; Färber M; Datta SA; Rein A; Rhoades E; Mothes W
    J Virol; 2014 Mar; 88(6):3577-85. PubMed ID: 24403576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myristate exposure in the human immunodeficiency virus type 1 matrix protein is modulated by pH.
    Fledderman EL; Fujii K; Ghanam RH; Waki K; Prevelige PE; Freed EO; Saad JS
    Biochemistry; 2010 Nov; 49(44):9551-62. PubMed ID: 20886905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.